| US11897948B2 | 13 February 2024 | Grant | US16179166 | Treatment of chronic kidney disease and other renal dysfunction using a gdf15 modulator | AVEO Pharmaceuticals Inc |
|---|---|---|---|---|---|
| US11725047B2 | 15 August 2023 | Grant | US16824034 | Anti-gdf-15 antibodies | AVEO Pharmaceuticals Inc |
| US11680108B2 | 20 June 2023 | Grant | US16667056 | Anti-erbb3 antibodies | AVEO Pharmaceuticals Inc |
| US11504365B2 | 22 November 2022 | Grant | US17720619 | Use of tivozanib to treat subjects with refractory cancer | AVEO Pharmaceuticals Inc |
| US11142573B2 | 12 October 2021 | Grant | US16097489 | Anti-notch3 antibody | AVEO Pharmaceuticals Inc |
